14-day Premium Trial Subscription Try For FreeTry Free
$11.42
-0.340 (-2.89%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $11.21 $12.67 Wednesday, 24th Apr 2024 DVAX stock ended at $11.42. This is 2.89% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.35% from a day low at $11.35 to a day high of $11.73.
90 days $11.21 $14.10
52 weeks $10.20 $15.15

Historical Dynavax Technologies Corporation prices

Date Open High Low Close Volume
Jan 05, 2024 $14.95 $14.95 $14.52 $14.74 1 669 695
Jan 04, 2024 $14.56 $15.01 $14.47 $14.98 2 288 572
Jan 03, 2024 $14.33 $14.48 $14.17 $14.42 1 470 202
Jan 02, 2024 $13.98 $14.54 $13.95 $14.38 1 441 653
Dec 29, 2023 $14.19 $14.19 $13.97 $13.98 1 020 608
Dec 28, 2023 $14.14 $14.34 $14.12 $14.23 1 141 840
Dec 27, 2023 $14.03 $14.15 $13.97 $14.13 973 343
Dec 26, 2023 $13.97 $14.14 $13.91 $14.03 927 551
Dec 22, 2023 $13.67 $13.86 $13.66 $13.84 1 204 386
Dec 21, 2023 $13.33 $13.65 $13.32 $13.62 1 364 746
Dec 20, 2023 $13.72 $13.72 $13.24 $13.26 2 121 365
Dec 19, 2023 $13.75 $13.93 $13.61 $13.83 1 456 227
Dec 18, 2023 $13.80 $13.80 $13.61 $13.64 1 891 481
Dec 15, 2023 $13.67 $14.07 $13.48 $13.66 4 645 356
Dec 14, 2023 $13.61 $13.76 $13.46 $13.57 1 583 258
Dec 13, 2023 $13.40 $13.47 $13.07 $13.45 2 167 972
Dec 12, 2023 $13.48 $13.48 $13.19 $13.39 1 626 407
Dec 11, 2023 $13.33 $13.51 $13.29 $13.41 1 069 000
Dec 08, 2023 $13.31 $13.48 $13.22 $13.31 1 058 331
Dec 07, 2023 $13.41 $13.55 $13.28 $13.45 1 359 836
Dec 06, 2023 $13.78 $13.86 $13.36 $13.40 1 798 219
Dec 05, 2023 $13.82 $13.90 $13.59 $13.76 1 242 065
Dec 04, 2023 $13.77 $13.97 $13.66 $13.92 1 244 378
Dec 01, 2023 $13.65 $13.89 $13.48 $13.79 1 828 964
Nov 30, 2023 $13.40 $13.83 $13.39 $13.70 1 633 493
Click to get the best stock tips daily for free!

About Dynavax Technologies Corporation

Dynavax Technologies Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a coll... DVAX Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT